Product Liability Hot Seat: Incretin Mimetics Follow Actos In Racking Up Claims
More than 3,000 plaintiffs claim Takeda’s diabetes drug Actos caused bladder cancer, while more than 50 cases have been brought alleging Januvia, Janument, Victoza and Byetta caused pancreatic cancer.
You may also be interested in...
Merck, AstraZeneca and Novo Nordisk's incretin mimetics win as district judge cites FDA’s history of rejecting pancreatic cancer warnings.
The agency announces that it is evaluating unpublished findings based on pancreatic tissue specimens from a few deceased patients; clinicians say ongoing prospective studies will determine how diabetes drugs affect the pancreas.
Bayer’s birth control pills Yasmin and Yaz face the most pharmaceutical product liability actions in federal court followed by Pfizer’s Prempro and GlaxoSmithKline’s Avandia. While GSK has settled the bulk of cases before a single trial, Merck and Novartis are winning Fosamax and Aredia jury verdicts.